{"publication_id":"57cdda93-cf6f-4497-b8fa-c2a05a658c90","traces":[{"claim_id":"claim_1","claim":"This evidence map surveys 19 independent metformin treatment sources drawn from the Tier-2 corpus and classified as direct findings. They vary across population, comparator, and/or endpoint and are catalogued by source in the Findings Map rather than pooled into one estimate — cross-population aggregation is not claimed. Each row records its own population, comparator, endpoint, and effect, so the spread of the literature and any tensions between findings remain explicit.","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_2","claim":"| Caenorhabditis elegans | control | Metformin causes an 86% increase in S-adenosylmethionine (SAMe) | 2025 doi:10.3390/ph18010055 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_3","claim":"| patients with type 2 diabetes mellitus… | baseline | MRI-PDFF decreased significantly with sitagliptin (15.5% ± 5.6% to 11.7% ± 5.0%, P = 0.001… | 2018 doi:10.1002/hep.30320 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_4","claim":"| genetically heterogeneous mice (ITP) | rapamycin alone (historical… | Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive o… | 2016 doi:10.1111/acel.12496 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_5","claim":"| mice on high-fat diet | without metformin | Clostridium cocleatum (0.10%±0.09%) abundances increased significantly after metformin tre… | 2014 doi:10.1128/aem.01357-14 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_6","claim":"| 342 overweight patients with newly dia… | — | this subgroup experienced a 39% (P = 0.010) risk reduction for myocardial infarction | 2011 doi:10.2337/dc10-2361 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]},{"claim_id":"claim_7","claim":"| A/J mice treated with tobacco carcinog… | — | Metformin decreased tumor burden by 72%, which correlated with decreased cellular prolifer… | 2010 doi:10.1158/1940-6207.capr-10-0055 |","candidate_sources":[{"study":"Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.","doi":"10.1007/s12325-025-03256-x","url":"https://pubmed.ncbi.nlm.nih.gov/40465202/"},{"study":"The Gut Microbiota-Related Antihyperglycemic Effect of Metformin","doi":"10.3390/ph18010055","url":"https://pubmed.ncbi.nlm.nih.gov/39861118/"},{"study":"Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.","doi":"10.21203/rs.3.rs-5920485/v1","url":"https://pubmed.ncbi.nlm.nih.gov/39989956/"},{"study":"Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.","doi":"10.1016/j.heliyon.2024.e37883","url":"https://pubmed.ncbi.nlm.nih.gov/39381110/"},{"study":"Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics","doi":"10.1111/acel.13802","url":"https://pubmed.ncbi.nlm.nih.gov/36864750/"}]}]}